378 related articles for article (PubMed ID: 23732810)
1. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
6. Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent.
Gopalakrishnan L; Ramana LN; Sethuraman S; Krishnan UM
Carbohydr Polym; 2014 Oct; 111():215-21. PubMed ID: 25037345
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
9. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B
J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial.
Kim S; Gaber MW; Zawaski JA; Zhang F; Richardson M; Zhang XA; Yang Y
Biomaterials; 2009 Sep; 30(27):4743-51. PubMed ID: 19501395
[TBL] [Abstract][Full Text] [Related]
12. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
13. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
Jang MK; Jeong YI; Nah JW
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and characterization of biotinylated chitosan nanoparticles].
Yao Q; Hou SX; Zhang X; Zhao G; Gou XJ; You JZ
Yao Xue Xue Bao; 2007 May; 42(5):557-61. PubMed ID: 17703783
[TBL] [Abstract][Full Text] [Related]
16. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
17. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
18. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer.
Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y
Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170
[TBL] [Abstract][Full Text] [Related]
19. Preparation of polysaccharide derivates chitosan-graft-poly(ɛ-caprolactone) amphiphilic copolymer micelles for 5-fluorouracil drug delivery.
Gu C; Le V; Lang M; Liu J
Colloids Surf B Biointerfaces; 2014 Apr; 116():745-50. PubMed ID: 24529474
[TBL] [Abstract][Full Text] [Related]
20. Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II.
Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
Int J Pharm; 2013 Nov; 456(2):499-507. PubMed ID: 23999222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
